KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Evolent Health (EVH) Shares Outstanding (2016 - 2026)

Evolent Health has reported Shares Outstanding over the past 12 years, most recently at $117.6 million for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 0.88% year-over-year to $117.6 million; the TTM value through Dec 2025 reached $117.6 million, up 0.88%, while the annual FY2025 figure was $117.6 million, 0.88% up from the prior year.
  • Shares Outstanding for Q4 2025 was $117.6 million at Evolent Health, roughly flat from $117.6 million in the prior quarter.
  • Over five years, Shares Outstanding peaked at $117.6 million in Q4 2025 and troughed at $86.8 million in Q1 2021.
  • A 5-year average of $106.5 million and a median of $113.9 million in 2023 define the central range for Shares Outstanding.
  • Biggest five-year swings in Shares Outstanding: grew 23.38% in 2023 and later increased 0.87% in 2025.
  • Year by year, Shares Outstanding stood at $90.8 million in 2021, then rose by 11.84% to $101.5 million in 2022, then increased by 13.72% to $115.4 million in 2023, then grew by 1.0% to $116.6 million in 2024, then increased by 0.88% to $117.6 million in 2025.
  • Business Quant data shows Shares Outstanding for EVH at $117.6 million in Q4 2025, $117.6 million in Q3 2025, and $117.5 million in Q2 2025.